Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rationally designed Human Cytomegalovirus gB nanoparticle vaccine with improved immunogenicity
Michela Perotti, Jessica Marcandalli, Davide Demurtas, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 12, pp. e1009169-e1009169
Open Access | Times Cited: 21

Showing 21 citing articles:

Antibodies to combat viral infections: development strategies and progress
Giuseppe Pantaleo, Bruno E. Correia, Craig Fenwick, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 9, pp. 676-696
Open Access | Times Cited: 154
Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation
Madeline R. Sponholtz, Patrick O. Byrne, Alison G. Lee, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 37
Open Access | Times Cited: 6
Proceedings of the Conference “CMV Vaccine Development—How Close Are We?” (27–28 September 2023)
Mark R. Schleiss, Chelsea M. Crooks, Krithika P. Karthigeyan, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1231-1231
Open Access | Times Cited: 4
Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV
Cara W. Chao, Kaitlin R. Sprouse, Marcos C. Miranda, et al.
Cell Reports (2024) Vol. 43, Iss. 12, pp. 115036-115036
Open Access | Times Cited: 4
Developing a Vaccine Against Human Cytomegalovirus: Identifying and Targeting HCMV’s Immunological Achilles’ Heel
Anastasia Lankina, Marta Brezmes Raposo, Alexander Hargreaves, et al.
Vaccines (2025) Vol. 13, Iss. 5, pp. 435-435
Open Access
Structure and Antigenicity of Kaposi's Sarcoma‐Associated Herpesvirus Glycoprotein B
Xin‐Yan Fang, Cong Sun, Chu Xie, et al.
Advanced Science (2025)
Open Access
Antigen spacing on protein nanoparticles influences antibody responses to vaccination
Daniel Ellis, Annie Dosey, Seyhan Boyoglu-Barnum, et al.
Cell Reports (2023) Vol. 42, Iss. 12, pp. 113552-113552
Open Access | Times Cited: 10
Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation
Madeline R. Sponholtz, Patrick O. Byrne, Alison G. Lee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
RAIN: machine learning-based identification for HIV-1 bNAbs
Mathilde Foglierini, Pauline Nortier, Rachel Schelling, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Myocarditis: causes, mechanisms, and evolving therapies
Tin Kyaw, Grant R. Drummond, Alex Bobik, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 3, pp. 225-238
Closed Access | Times Cited: 9
Design and immunological evaluation of two-component protein nanoparticle vaccines for East Coast fever
Anna Lacasta, Hyung Chan Kim, Elizabeth Kepl, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 7
Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV
Cara W. Chao, Kaitlin R. Sprouse, Marcos C. Miranda, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Prevention of Congenital Cytomegalovirus Infection with Vaccines: State of the Art
Susanna Esposito, Giulia Chiopris, Giulia Messina, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 523-523
Open Access | Times Cited: 13
Evasion of the Host Immune Response by Betaherpesviruses
Daniel Sausen, Kirstin Reed, Maimoona Bhutta, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7503-7503
Open Access | Times Cited: 12
An Algorithm for the Development of a Recombinant Antiherpetic Subunit Vaccine Combining the Crystal Structure Analysis, AlphaFold2-Based Modeling, and Immunoinformatics
Tatiana V. Rakitina, Е. В. Смирнова, Д. Д. Подшивалов, et al.
Crystals (2023) Vol. 13, Iss. 10, pp. 1416-1416
Open Access | Times Cited: 4
Sequencing Directly from Clinical Specimens Reveals Genetic Variations in HCMV-Encoded Chemokine Receptor US28 That May Influence Antibody Levels and Interactions with Human Chemokines
Shelley Waters, Mark Agostino, Silvia Lee, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 2
Open Access | Times Cited: 5
A trimeric capable gB CMV vaccine provides limited protection against a highly cell associated and epithelial tropic strain of cytomegalovirus in guinea pigs
K. Yeon Choi, Nadia S. El‐Hamdi, Alistair McGregor
Journal of General Virology (2021) Vol. 102, Iss. 3
Open Access | Times Cited: 4
Predicting the Immunogenic Potential of Herpes Virus Type 2 Glycoprotein B Antigenic Domains
Tatiana V. Rakitina, В. И. Тимофеев, A. S. Ivanovsky, et al.
Nanobiotechnology Reports (2024) Vol. 19, Iss. 6, pp. 1002-1007
Closed Access
Antigen spacing on protein nanoparticles influences antibody responses to vaccination
Daniel Ellis, Annie Dosey, Seyhan Boyoglu-Barnum, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Cytomegalovirus Vaccines
Mark R. Schleiss
Elsevier eBooks (2023), pp. 258-274.e9
Closed Access
Novel Potent Neutralizing Antibodies Revealed the Domain I of HCMV Glycoprotein B for Vaccine Design
Changwen Wu, Yuanbao Ai, Yayu Wang, et al.
SSRN Electronic Journal (2021)
Closed Access
Page 1

Scroll to top